Ładuje się......
Metastatic pancreatic cancer: Is there a light at the end of the tunnel?
Due to extremely poor prognosis, pancreatic cancer (PDAC) represents the fourth leading cause of cancer-related death in Western countries. For more than a decade, gemcitabine (Gem) has been the mainstay of first-line PDAC treatment. Many efforts aimed at improving single-agent Gem efficacy by eithe...
Zapisane w:
| Wydane w: | World J Gastroenterol |
|---|---|
| Główni autorzy: | , , , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Baishideng Publishing Group Inc
2015
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4408451/ https://ncbi.nlm.nih.gov/pubmed/25944992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i16.4788 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|